Skip to content

Perspective Therapeutics CATX Change in Inventories

Change in Inventories at other companies

Eli Lilly logo
Eli LillyLLY
$1.17B+86.3%
Lantheus Holdings logo
Lantheus HoldingsLNTH
-$2.11M-660%
Precigen logo
PrecigenPGEN
$4.88M
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$171M+11.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$4M+300%
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
$21.8M+296%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Perspective Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's change in inventories?
Perspective Therapeutics (CATX) reported change in inventories of $0 in Q3 2025.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.